Trial intelligence / Profile preview

Efficacy and Safety of MF/F vs MF in Children with Persistent Asthma

NCT02741271Phase 3Completed

Sponsor
Organon & Co.
Start
May 2016
Primary completion
Dec 2017
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of mometasone furoate + formoterol fumarate in asthma, sponsored by Organon & Co.. Started May 2016; status: completed.

02

Drugs

mometasone furoate + formoterol fumarate
03

Conditions

asthma

Beyond the preview

Go deeper on NCT02741271.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02741271.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call